online currency bit- Top Knowledge

Huabei Pharmaceutical Co., Ltd.: Four kinds of drugs under the company are planned to be selected for national centralized drug procurement. Huabei Pharmaceutical announced that the company and its subsidiary Xiantai Company participated in the tenth batch of national centralized drug procurement, and all four varieties are planned to be selected, including penicillin sodium for injection, piperacillin sodium for injection, ampicillin sodium for injection and sulbactam sodium for injection. The price of the drug to be selected this time has decreased compared with the original sales price. In 2023, the sales income of penicillin sodium for injection was 129 million yuan, accounting for 1.28% of the annual operating income. If the bid is confirmed and the purchase and sale contract is signed, the company will fully guarantee the supply according to the demand of the selected area, and promote the increment of related products in the selected area and the development of the off-standard market.State Financial Supervision and Administration: Actively guide banks and insurance institutions to reduce costs and increase efficiency, and broaden capital replenishment channels. On December 13, the Party Committee of the State Financial Supervision and Administration held a meeting to convey the spirit of studying the Central Economic Work Conference, and to study and deploy implementation measures in light of the requirements of the National Financial System Work Conference. The meeting called for promoting the high-quality development of the banking and insurance industry, actively guiding banking and insurance institutions to reduce costs and increase efficiency, broadening capital replenishment channels, and improving sustainable development capabilities. Promote high-level financial openness with higher standards and greater efforts, and attract more foreign financial institutions and long-term capital to set up businesses in China.Governor of Poland's central bank: Poland will continue to achieve the CPI target.

The US import price index in November was 1.3% year-on-year, expected to be 1%, and the previous value was 0.8%. The annual export price index of the United States in November was 0.8%, expected to be 0.3%, and the previous value was-0.10%.Musk received an ultimatum from the SEC or faced multiple accusations, and the long-term confrontation between the US SEC and Musk escalated again. On December 12th, local time, Alex spiro, a lawyer of Musk, wrote to Gary Gensler, the outgoing chairman of the SEC, accusing the agency of launching an "ulterior motive action" against Musk, and revealed that the SEC had restarted the investigation of Neuralink, a brain-computer interface company owned by Musk. According to the contents of the letter, the SEC asked Musk to accept the settlement agreement within 48 hours and pay the fine, otherwise he would face "multiple accusations". These allegations are related to Musk's stock investment behavior before the acquisition of Twitter (now "X") in 2022, involving trading time and the legality of information disclosure. It was mentioned in the letter that the accusation originated from an investigation that lasted for several years, and the SEC recently issued a subpoena to Musk's lawyer, asking him to provide testimony. Alex spiro said that he had explicitly refused to cooperate and accused the agency of "political motives". Musk also posted a letter from his lawyer to Gary Gensler on social media, with the text "Gary, how could you do this to me" and a crying emoji. Alex spiro also asked in his letter who was directing the SEC's actions. Alex spiro emphasized that the SEC's "harassment" of Musk and its affiliates for six years has deviated from the original intention of seeking the truth and become an improper pressure. At present, the SEC has not commented on this. In addition, the letter said that the SEC also restarted the investigation of Neuralink, a brain-computer interface company owned by Musk. This autumn, the animal protection organization "Committee of Responsible Medical Doctors" and four US congressmen asked the SEC to investigate Neuralink, accusing it of securities fraud through misleading propaganda. (Securities Times)Analysis: the potential weakness of Canada's manufacturing industry still exists. Forexlive: Canada's manufacturing industry rebounded strongly, mainly driven by petroleum products and automobiles. However, the year-on-year data decline shows that some potential weakness still exists.

Haitian Weiye, a soy sauce manufacturer, is reported to have hired a bank to handle the listing in Hong Kong. According to informed sources, Haitian Weiye, one of the largest condiment manufacturers in China, has hired CICC, Goldman Sachs and Morgan Stanley to handle the second listing in Hong Kong, which may raise at least $1.5 billion. According to people familiar with the matter, Haitian plans to submit a preliminary prospectus to the Hong Kong Stock Exchange as early as January.Kang Enbei: Amikacin Sulfate Injection is planned to win the bid for the tenth batch of national centralized drug purchase. On December 12th, Kang Enbei and its wholly-owned subsidiary Jinhua Kang Enbei participated in the bidding for the tenth batch of national centralized drug purchase organized by the National Joint Procurement Office for Centralized Drug Purchase and Use. After the bid opening and bid evaluation by the Joint Procurement Office, the company's product Amikacin Sulfate Injection plans to win the bid for this centralized procurement, and the supply provinces have been selected according to the market potential of each province. The successful results will be officially released after being publicized by the Joint Procurement Office. Amikacin sulfate injection is suitable for the treatment of serious infections caused by Pseudomonas aeruginosa, other Pseudomonas, Escherichia coli and other sensitive gram-negative bacilli and Staphylococcus (methicillin-sensitive strains). Compared with the original price, the price of the product to be selected this time has dropped to a certain extent.The balance of A-share financing reached a new high in nine years. Since the fourth quarter, the net purchase amount of financing in 12 industries has exceeded 10 billion yuan. As of December 12, the balance of A-share financing was 1,882.656 billion yuan, a new high since August 2015. Since the fourth quarter, the market financing balance has grown rapidly. The latest financing balance was 1,882.656 billion yuan, an increase of 452.006 billion yuan or 31.59% compared with the financing balance of 1,430.650 billion yuan on September 30. During the period, the net purchase amount of financing in 12 industries exceeded 10 billion yuan. Electronics, computers, non-bank finance and machinery and equipment ranked in the top four, with the amounts of 77.849 billion yuan, 50.709 billion yuan, 49.201 billion yuan and 31.068 billion yuan in turn. In proportion, the latest financing balance of electronics, mechanical equipment and computers increased by more than 50% compared with that before the fourth quarter; The growth rate of media, communications and automobiles is also higher than 40%. In terms of individual stocks, Oriental Fortune received the most financing customers, with a net purchase amount of 15.892 billion yuan; SMIC ranked second with a net purchase of 5.515 billion yuan; Jianghuai Automobile ranked third with a net purchase of 4.122 billion yuan. Among the TOP20 stocks, there are many non-bank financial, automobile, computer and semiconductor stocks, accounting for 50% of the total. (data treasure)